The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,792.50
Bid: 1,792.00
Ask: 1,793.00
Change: 14.50 (0.82%)
Spread: 1.00 (0.056%)
Open: 1,780.00
High: 1,793.00
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Designer Daniel Lee replaces Riccardo Tisci at Burberry

Wed, 28th Sep 2022 09:44

Former Bottega Veneta creative head joins British brand

*

Tisci steps down after nearly five years

*

Move follows arrival of new CEO earlier this year

LONDON, Sept 28 (Reuters) - Burberry Group has appointed Daniel Lee as its new chief creative officer, replacing Riccardo Tisci, who is stepping down after presenting his final runway show for the British luxury brand on Monday.

The end of Tisci's near five-year tenure at Burberry follows the arrival of Jonathan Akeroyd as new chief executive earlier this year. Chief Financial Officier Julie Brown is also leaving to join drugmaker GSK.

Lee was creative director at Italy's Bottega Veneta from 2018 to 2021, and has previously worked at Celine, Maison Margiela, Balenciaga and Donna Karan, Burberry said on Wednesday.

The 35-year-old Central Saint Martins graduate successfully ignited the Italian label's popularity with younger consumers and boosted sales with popular accessories including pillowy leather clutch handbags and slip-on heels.

He departed suddenly from the Kering-owned brand last November, just three years into his position.

Lee, born in Yorkshire where Burberry manufactures its famous trench coats, said he was honoured to join the British fashion house and build on Tisci's legacy.

Shares in Burberry rose 3.2% in early deals on Wednesday, one of the few gainers in the FTSE 100 index which was 2% lower.

Stifel analyst Rogerio Fujimori said the change should be seen as a long-term positive given Lee's successful track record in ready-to-wear.

Luca Solca at Bernstein said Lee could develop product categories such as handbags and shoes.

"So far, the British brand has struggled to make its mark in these categories and create high profile iconic products," he said. "Daniel could open this opportunity."

However, the change could also increase the level of uncertainty and perceived lack of direction, following recent departures of the CEO and CFO and as the macroeconomic situation potentially deteriorates, said Thomas Chauvet of Citi.

Tisci was the creative force behind former chief executive Marco Gobbetti's strategy to elevate the position of the 166-year-old brand in the luxury sector.

His designs, many of which featured a new Thomas Burberry "TB" monogram, strengthened the brand's streetwear offer and attracted a younger and more diverse community of customers.

Stifel's Fujimori said his collections were however "not able to create the strong buzz seen at the hottest luxury brands in the past five years", such as Dior, YSL, Bottega Veneta and Balenciaga, which Burberry needed to accelerate top-line growth. (Reporting by Paul Sandle in London, Mimosa Spencer in Paris and Yadarisa Shabong in Bengaluru; Editing by Kate Holton, Sachin Ravikumar and Emelia Sithole-Matarise)

More News
Today 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
Today 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
Today 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
Today 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.